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INTRODUCTION
The rhesus monkey (macaca mulatta) is being
used in the development of a non-human pri-
mate model that will study neural tissue trans-
plantation as a potential treatment for degener-
ative diseases of the central nervous system
(CNS). The overall quality of this model rests on
several factors, including survival, growth, and
long-term function of the grafted tissues.
Characterization of the immunological re-
sponse of the CNS to allografts in primates is
essential in the development of effective neural
transplantation techniques. The apparent lack of
systemic humoral and cellular sensitization as
well as local tissue cytotoxic activity is critical in
the ultimate survival of grafted tissues and effi-
cacy of treatment. Appreciation of recipient
humoral and cellular responses to transplanted
tissues should maximize graft survival and limit
graft rejection via immune system suppression.
Host sensitization to donor specific tissues
(systemic humoral and cellular response) and
surgical site reaction (mononuclear cell infiltra-
tion) are of primary concern. Means by which to
monitor host response to grafted tissues may
then be determined and allow assessment of
possible modalities of immunological mani-
pulation.
METHODS
Immunological studies were performed on
surgical site tissues (autografts and non-grafted),
peripheral blood samples, and cerebrospinal
fluid (CSF) from the rhesus monkeys. Both fetal
mesencephalic allografts and adrenal medullary
autografts were evaluated. Peripheral blood was
obtained from fetal grafted Bonnett monkeys
(macaca radiata) and the donor parent from the
University of Colorado.
Ten monkeys at the Yerkes Regional Primate
Research Center were evaluated for CNS graft-
ing. These monkeys were trained to perform
specific tasks and were injected with 1-methyl-4-
phenyl-l,2,3,6-tetrahydropyridine (MPTP, 0.4
mg/kg) via left internal carotid to induce parkin-
sonism. After three to four months of functional
impairment quantitation, fetal mesencephalic
allograffs (N=2) or adrenal medullary autograffs
(N=4) were transplanted to the left caudate
nucleus. Sham operations were performed on
four animals. Prior to operation, CSF was sam-
pled via percutaneous cisterna magna punctures
and peripheral blood was drawn monthly. Func-
tional impairment was again quantified for eight
to twelve months during which time CSF was
again sampled monthly and peripheral blood
was assayed at one, three, and six months. The
monkeys were sacrificed at eight to twelve
months post-operatively for histological and
immunocytochemical.study of graft site.
Leukocyte and erythrocyte counts were per-
formed on all CSF samples. Surface markers
specific for mononuclear cells were used to iden-
tify cellular infiltrates in tissues one week, one
month, and one year after surgery. Markers in-
cluded antibodies to CD2, CDJ, CD4, CDS,
CD12, CD20, CD25, and CD68. Relative evalua-
tion of major histocompatibility complex (MHC)
class I and class II antigenic expression was also
performed as were functional studies to detect
donor specific cytotoxic T-cells, and levels ofNK
and LAK cells. Serum samples were also assayed
for presence of donor specific cytotoxic anti-
bodies.
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RESULTS
Peripheral blood assays from both fetal mes-
encephalic and adrenal medullary grafted
animals revealed no significant changes in the
frequency of mononuclear cell subsets, including
total T-cells, CD4 (helper T-cells), CD8
(suppressor T-cells), B-cells, or macrophages
when preoperative samples were compared to
post-transplant samples. Cytotoxicity evaluations
failed to disclose any sign of humoral or cellular
donor specific sensitization in hosts receiving
mesencephalic allografts. Functional evaluations
failed to demonstrate changes in the relative
levels of NK or LAK cells in experimental as
compared with non-transplanted surgical control
samples.
CSF samples throughout the study showed no
significant mononuclear cell count elevation.
Surface immunoreactivity utilizing antibodies
to mononuclear cell specific antigens disclosed
evidence of helper T-cell, suppressor T-cell,
activator T-cell, B-cell, and macrophage activity
in tissues from ungrafted operative site at one
week, one month, and up to one year postopera-
tively. There appeared to be an overall decrease
in surface marker evidence with time. Interest-
ingly, the same degree of response appeared to
occur whether or not an autograft was implanted
to the surgical site. Allograft tissue data is not
yet available.
Relative to splenic tissues, MHC class I anti-
gens were expressed at very low levels and MHC
class II antigen levels were undetectable in brain
tissues taken from surgical sites with or without
graft at one week, one month, and one year
postoperatively.
CONCLUSION
These results suggest that allografts to the
CNS do not evoke donor specific lymphocyto-
toxic sensitization. There is evidence for
mononuclear cellular reaction in the surgical site
whether or not a graft is placed. MHC class I
antigens have been detected at very low levels in
the brain tissue. Future studies include evalua-
tion of host sensitization to subsequent antigenic
challenges from the donor and suppression of
immunological response using various pharma-
cological means.
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